Skin Reactions Related to Thoracic Implantable Chamber Dressings
This study is investigating skin reactions that can happen around the dressings used for chest ports. These ports are common devices, often used in cancer treatment, to deliver chemotherapy directly into the bloodstream without damaging veins. While useful, some people develop skin issues like redness, itching, or soreness where the dressing sits. Doctors have noticed these reactions are quite common, and this study aims to understand why they happen and how often. They will look at factors like age, other treatments, the type of dressing, and even the weather. The goal is to find ways to make treatment more comfortable for patients and improve care practices.
At a glance
What is this study about?
When you're having certain treatments, like chemotherapy for cancer, doctors sometimes insert a small device under your skin in your chest. This device, often called a port or a central line, helps nurses give you medicines directly into a large vein without needing to find a new vein every time. It's a very common and helpful way to receive treatment, especially if you need treatment often or if the medicine would otherwise harm your smaller veins.
After the port is put in, it needs a special dressing on your skin to keep it clean and protected. While these ports are incredibly beneficial, doctors have noticed that some people get skin reactions where this dressing is. These can include things like the skin becoming red, itchy, or a bit raw or sore. While other problems with ports, like infections, have been studied a lot over the years, less is known about these skin reactions.
This study wants to understand more about these skin reactions. Researchers will observe 500 new chemotherapy patients to see how often these reactions happen. They will also look into different reasons why they might occur, such as individual patient factors (like age or other health conditions), the chemotherapy medicines themselves, the type of dressing used and how it's put on, how long the dressing stays on, and even environmental factors like the weather. The aim is to gather information that could help improve how dressings are chosen and applied in the future, making treatment more comfortable for patients.
Key takeaways
- This study observes skin reactions to chest port dressings during chemotherapy.
- It aims to understand how common these reactions are and what causes them.
- Participation involves observation during your regular treatment, not new medicines.
- The findings could improve comfort and care for future patients.
- You must be an adult starting first-line chemotherapy with a chest port to be eligible.
Who may be eligible?
To join this study, you must be an adult aged 18 or over and starting your very first course of chemotherapy. You also need to have a specific type of device called a 'thoracic PAC' (a port in your chest) for your treatment.
There are certain reasons why you wouldn't be able to join. For example, if you have a different type of port (like one in your arm or leg), if you're taking specific new antibody treatments, or if you already have a serious skin problem that needs treatment near where the dressing would go. Also, if you're being treated for blood cancer, or if you're unable to take part for legal, social, or personal reasons, you wouldn't be eligible.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you starting your first course of chemotherapy treatment?
- Do you have a 'port' (thoracic PAC) in your chest for your treatment?
- Are you NOT being treated for a blood cancer?
- Do you NOT have a serious skin problem already where the dressing would be?
What does participation involve?
If you join this study, you won't be given any new medication or have different treatments. Instead, the doctors and nurses will simply observe and record any skin reactions you might have around your chest port dressing, as part of your regular chemotherapy treatment. They will gather information about your general health, the treatments you're receiving, and details about your dressing. This observation would happen alongside your usual care visits. The exact duration of your participation would depend on your chemotherapy schedule, as the study focuses on patients starting their first line of treatment.
Potential risks and benefits
Locations (3)
- Institut CurieVerified postcodeParis, France· Recruiting
- Centre Hospitalier de Polynésie Française CHPFVerified postcodePirae, French Polynesia· Not yet recruiting
- Hôpital UturoaVerified postcodeUturoa, French Polynesia· Not yet recruiting
Common questions
What is a 'thoracic implantable chamber'?
It's a small device, also known as a port, placed under the skin in your chest. It helps deliver medicines directly into a vein for treatments like chemotherapy.
What kind of skin reactions are they looking for?
They are looking for redness, itching, or soreness on the skin where the port dressing is applied.
Will I have to take any new medicines?
No, you won't be given any new medicines. The study is about observing skin reactions to your usual treatment dressings.
Who is funding this study?
The study aims to improve patient care practices, but the funding source is not detailed in this information.
What will happen with the results of this study?
The results will help doctors understand why these skin reactions happen, which could lead to better ways of managing dressings for patients in the future.
How to find out more
Betty LIMIER
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.